All the news Showing 10 of 448 articles from: TherapiesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources The Fair Pricing Coalition Expresses Dismay at the Price of Merck's Newly Approved Hepatitis C Drug Thebody.com / 18 May 2011 Merck, Roche to Work Together on Hepatitis C Treatments San Francisco Chronicle / 18 May 2011 Getting Ready; Telaprevir or Boceprevir ? HCV New Drugs Research / 18 May 2011 Merck’s Hepatitis C Drug Wins F.D.A. Approval New York Times / 16 May 2011 Vertex hepatitis C drug gets glowing endorsement Reuters / 29 April 2011 US FDA panel backs Merck hepatitis drug Reuters / 28 April 2011 Some Biotechs May Benefit From Hepatitis C Treatment Market Shift Seeking Alpha / 27 April 2011 Merck- Boceprevir, Vertex-Telaprevir Prep for Hep C Drug Panels The Street / 21 April 2011 European Gastroenterologists Will Prescribe Telaprevir and Boceprevir to Nonresponder and Treatment-Naive Patients Following Launch, Leading to Higher Treatment Costs Than Interviewed Payers Expect Business Wire / 19 April 2011 Pegylated Interferon Lambda Boosts Response with Few Side Effects HIVandhepatitis.com / 05 April 2011 ← Prev1...4142434445Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds